M&As aren't enough: why pharmaceutical companies need new business models

Nabila Amarsy
November 19, 2015
#
 min read
topics
Business Model Canvas
Business Models
Health

Merger and acquisitions have boomed in the pharmaceutical industry these past few years. In this video, I illustrate the motives behind these M&As, why they're not enough to drive long-term growth, and how pharma companies can address the key challenges of their industry.

Music: Matti Palanen, 'Clouds fly with me'

related reads

No items found.

About the speakers

Nabila Amarsy
by 
Nabila Amarsy
November 19, 2015
Share

Download your free copy of this whitepaper now

  • 1
  • 2
  • 3
related reads

Explore other examples

Read our blog
No items found.
Team member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatar
Let's talk
Whether you’re looking for more information or you’re ready to start a project, we’re ready to help.
Thanks for your interest in our solutions. We will be in touch with you soon.
M&As aren't enough: why pharmaceutical companies need new business models
Examples

M&As aren't enough: why pharmaceutical companies need new business models

M&As aren't enough: why pharmaceutical companies need new business models
Examples

M&As aren't enough: why pharmaceutical companies need new business models

November 19, 2015
#
 min read
topics
Business Model Canvas
Business Models
Health

Merger and acquisitions have boomed in the pharmaceutical industry these past few years. In this video, I illustrate the motives behind these M&As, why they're not enough to drive long-term growth, and how pharma companies can address the key challenges of their industry.

Music: Matti Palanen, 'Clouds fly with me'

related reads
No items found.
M&As aren't enough: why pharmaceutical companies need new business models

Merger and acquisitions have boomed in the pharmaceutical industry these past few years. In this video, I illustrate the motives behind these M&As, why they're not enough to drive long-term growth, and how pharma companies can address the key challenges of their industry.

Thanks for your interest in 
M&As aren't enough: why pharmaceutical companies need new business models
M&As aren't enough: why pharmaceutical companies need new business models
ONLINE COURSe

Read more
Team member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatarTeam member avatar
Let's talk
Whether you’re looking for more information or you’re ready to start a project, we’re ready to help.
Thanks for your interest in our solutions. We will be in touch with you soon.